HYDRA BIOSCIENCES
DEAD

Serial Number

76296817

Owner

Hydra Biosciences, Inc.

Attorney

Michael J. Bevilacqua

Filing Date

Aug 8, 2001

Add to watchlist:

No watchlists yet
View on USPTO

HYDRA BIOSCIENCES Trademark

Serial Number: 76296817

HYDRA BIOSCIENCES is a trademark filed by Hydra Biosciences, Inc. on August 8, 2001. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Hydra Biosciences, Inc. (8 trademarks)

790 MEMORIAL DRIVE
CAMBRIDGE, MA 02139

Entity Type: 03

Trademark Details

Filing Date

August 8, 2001

Registration Date

Not Registered

Published for Opposition

September 28, 2004

Goods & Services

Pharmaceuticals preparations for regenerating human tissues and organs, for blocking or promoting vessel development, and for treatment of human disease where the treatment involves generation of, interference with or effects upon one or more signaling molecules; pharmaceutical preparations in the nature of biologicals for regenerating human tissues and organs, for blocking or promoting vessel development, and for treatment of human disease where the treatment involves generation of interference with or effects upon one or more signaling molecules; and pharmaceutical preparations in the nature of genetic therapies for regenerating human tissues and organs, for blocking or promoting vessel development, and for treatment of human disease where the treatment involves generation of, interference with or effects upon one or more signaling molecules; oral contraceptives; spermicides; tests and assays composed primarily of mammalian cells, ion channels, signaling molecules, dedifferentiated or dedifferentiating cells, and cellular contractile organizational structures for identifying molecules that can induce desirable cardiovascular, reproductive, genitourinary, gastrointestinal, infectious, hematologic, oncologic, metabolic, neurologic, pulmonary, immunologic, renal, rheumatologic, dermatologic or vision results; and tests and assays composed primarily of mammalian cells, ion channels, signaling molecules, dedifferentiated or dedifferentiating cells, and cellular contractile organizational structures for identifying a risk of cardiovascular, reproductive, genitourinary, gastrointestinal, infectious, hematologic, oncologic, metabolic, neurologic, pulmonary, immunologic, renal, rheumatologic, dermatologic and vision diseases

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Aug 24, 2006 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 24, 2006 ABN6
SOU EXTENSION 2 GRANTED
Jan 13, 2006 EX2G
SOU EXTENSION 2 FILED
Dec 21, 2005 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 21, 2005 EEXT
SOU EXTENSION 1 GRANTED
May 25, 2005 EX1G
SOU EXTENSION 1 FILED
May 25, 2005 EXT1
SOU TEAS EXTENSION RECEIVED
May 25, 2005 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 21, 2004 NOAM
PUBLISHED FOR OPPOSITION
Sep 28, 2004 PUBO
NOTICE OF PUBLICATION
Sep 8, 2004 NPUB
ASSIGNED TO LIE
Jul 30, 2004 ALIE
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 27, 2004 PREV
ASSIGNED TO LIE
Jul 27, 2004 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 21, 2004 CNSA
CASE FILE IN TICRS
Mar 3, 2004 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2004 CRFA
PAPER RECEIVED
Feb 17, 2004 MAIL
NON-FINAL ACTION MAILED
Aug 22, 2003 CNRT
ASSIGNED TO EXAMINER
Jun 13, 2003 DOCK
REINSTATED
Jun 3, 2003 REIN
PAPER RECEIVED
Aug 26, 2002 MAIL
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 6, 2002 ABN2
PAPER RECEIVED
Mar 25, 2002 MAIL
NON-FINAL ACTION MAILED
Sep 27, 2001 CNRT
NON-FINAL ACTION MAILED
Sep 24, 2001 CNRT
ASSIGNED TO EXAMINER
Sep 19, 2001 DOCK
ASSIGNED TO EXAMINER
Sep 17, 2001 DOCK